Safety of low-density lipoprotein cholesterol reduction with atorvastatin versus simvastatin in a coronary heart disease population (the TARGET TANGIBLE Trial)

Winfried März, Helmut Wollschläger, Gernot Klein, Albrecht Neiß, Martin Wehling

Open source

DOI
10.1016/s0002-9149(99)00183-6
Published
1999-07
Container
The American Journal of Cardiology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0002-9149-99-00183-6,
  title = {Safety of low-density lipoprotein cholesterol reduction with atorvastatin versus simvastatin in a coronary heart disease population (the TARGET TANGIBLE Trial)},
  author = {Winfried März and Helmut Wollschläger and Gernot Klein and Albrecht Neiß and Martin Wehling},
  year = {1999},
  journal = {The American Journal of Cardiology},
  doi = {10.1016/s0002-9149(99)00183-6},
  url = {https://doi.org/10.1016/s0002-9149(99)00183-6}
}

RIS

TY  - JOUR
TI  - Safety of low-density lipoprotein cholesterol reduction with atorvastatin versus simvastatin in a coronary heart disease population (the TARGET TANGIBLE Trial)
AU  - Winfried März
AU  - Helmut Wollschläger
AU  - Gernot Klein
AU  - Albrecht Neiß
AU  - Martin Wehling
PY  - 1999
JO  - The American Journal of Cardiology
DO  - 10.1016/s0002-9149(99)00183-6
UR  - https://doi.org/10.1016/s0002-9149(99)00183-6
ER  - 

APA

März, W., Wollschläger, H., Klein, G., Neiß, A., & Wehling, M. (1999). Safety of low-density lipoprotein cholesterol reduction with atorvastatin versus simvastatin in a coronary heart disease population (the TARGET TANGIBLE Trial). The American Journal of Cardiology. https://doi.org/10.1016/s0002-9149(99)00183-6

Source records